Law's Sharona Hoffman explains why insurers are dropping weight-loss drug coverage

Insurers pull back on paying for weight-loss drugs

Ideastream: Sharona Hoffman, the Edgar A. Hahn Professor of Law and co-director of the Law-Medicine Center, said insurers are increasingly reluctant to cover costly GLP-1 drugs when used primarily for weight loss, though medically necessary conditions may qualify. She encouraged patients to appeal denials with supporting medical documentation and warned against unregulated online sellers and medical spas, emphasizing the importance of physician oversight.